Long noncoding RNA PR11-387H17.6 as a potential novel diagnostic biomarker of atherosclerotic renal artery stenosis

References

• Johansson M, Herlitz H, Jensen G, et al. Increased cardiovascular mortality in hypertensive patients with renal artery stenosis. Relation to sympathetic activation, renal function and treatment regimens. J Hypertens. 1999;17(12 Pt 1):1743–1750.
   PubMed Web of Science ®Google Scholar
• Zeller T. Renal artery stenosis: epidemiology, clinical manifestation, and percutaneous endovascular therapy. J Interv Cardiol. 2005;18(6):497–506.
   PubMedGoogle Scholar
• Rihal CS, Textor SC, Breen JF, et al. Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography. Mayo Clin Proc. 2002;77(4):309–316.
   PubMed Web of Science ®Google Scholar
• Olin JW. Role of duplex ultrasonography in screening for significant renal artery disease. Urol Clin North Am. 1994;21(2):215–226.
   PubMed Web of Science ®Google Scholar
• Goncalves JA, Amorim JE, Soares Neto MM, et al. Clinical efficacy of percutaneous renal revascularization with stent placement in atherosclerotic renovascular disease. Arq Brasil Cardiol. 2007;88(1):85–90.
   PubMed Web of Science ®Google Scholar
• Cooper CJ, Murphy TP, Cutlip DE, et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med. 2014;370(1):13–22.
   PubMed Web of Science ®Google Scholar
• Santosh B, Varshney A, Yadava PK. Non-coding RNAs: biological functions and applications. Cell Biochem Funct. 2015;33(1):14–22.
   PubMed Web of Science ®Google Scholar
• Batista PJ, Chang HY. Long noncoding RNAs: cellular address codes in development and disease. Cell. 2013;152(6):1298–1307.
   PubMed Web of Science ®Google Scholar
• Reis EM, Verjovski-Almeida S. Perspectives of long non-coding RNAs in cancer diagnostics. Front Genet. 2012;3:32.
   PubMedGoogle Scholar
• Kataoka M, Wang DZ. Non-coding RNAs including miRNAs and lncRNAs in cardiovascular biology and disease. Cells. 2014;3(3):883–898.
   PubMedGoogle Scholar
• Iaconetti C, Gareri C, Polimeni A, et al. Non-coding RNAs: the "dark matter" of cardiovascular pathophysiology. Int J Mol Sci. 2013;14(10):19987–20018.
   PubMed Web of Science ®Google Scholar
• Mathiyalagan P, Keating ST, Du XJ, et al. Interplay of chromatin modifications and non-coding RNAs in the heart. Epigenetics. 2014;9(1):101–112.
   PubMed Web of Science ®Google Scholar
• Kumarswamy R, Bauters C, Volkmann I, et al. Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure. Circ Res. 2014;114(10):1569–1575.
   PubMed Web of Science ®Google Scholar
• Yang KC, Yamada KA, Patel AY, et al. Deep RNA sequencing reveals dynamic regulation of myocardial noncoding RNAs in failing human heart and remodeling with mechanical circulatory support. Circulation. 2014;129(9):1009–1021.
   PubMed Web of Science ®Google Scholar
• Han P, Li W, Lin CH, et al. A long noncoding RNA protects the heart from pathological hypertrophy. Nature. 2014;514(7520):102–106.
   PubMed Web of Science ®Google Scholar
• Wang K, Liu F, Zhou LY, et al. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489. Circ Res. 2014;114(9):1377–1388.
   PubMed Web of Science ®Google Scholar
• Liu Y, Ferguson JF, Xue C, et al. Tissue-specific RNA-Seq in human evoked inflammation identifies blood and adipose LincRNA signatures of cardiometabolic diseases. Arterioscler Thromb Vasc Biol. 2014;34(4):902–912.
   PubMed Web of Science ®Google Scholar
• Ishii N, Ozaki K, Sato H, et al. Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction. J Hum Genet. 2006;51(12):1087–1099.
   PubMed Web of Science ®Google Scholar
• Bai Y, Nie S, Jiang G, et al. Regulation of CARD8 expression by ANRIL and association of CARD8 single nucleotide polymorphism rs2043211 (p.C10X) with ischemic stroke. Stroke. 2014;45(2):383–388.
   PubMed Web of Science ®Google Scholar
• Holdt LM, Hoffmann S, Sass K, et al. Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regulation of gene networks. PLoS Genet. 2013;9(7):e1003588.
   PubMed Web of Science ®Google Scholar
• Levine GN, Bates ER, Blankenship JC, et al. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. J Am Coll Cardiol. 2016;67(10):1235–1250.
   PubMed Web of Science ®Google Scholar
• Cai Y, Yang Y, Chen X, et al. Circulating "LncPPARδ" from monocytes as a novel biomarker for coronary artery diseases. Medicine. 2016;95(6):e2360.
   PubMed Web of Science ®Google Scholar
• Lao D, Parasher PS, Cho KC, et al. Atherosclerotic renal artery stenosis-diagnosis and treatment. Mayo Clin Proc. 2011;86(7):649–657.
   PubMed Web of Science ®Google Scholar
• Chade AR, Lerman A, Lerman LO. Kidney in early atherosclerosis. Hypertension. 2005;45(6):1042–1049.
   PubMed Web of Science ®Google Scholar
• Wu G, Cai J, Han Y, et al. LincRNA-p21 regulates neointima formation, vascular smooth muscle cell proliferation, apoptosis, and atherosclerosis by enhancing p53 activity. Circulation. 2014;130(17):1452–1465.
   PubMed Web of Science ®Google Scholar
• Zolk O, Solbach TF, Eschenhagen T, et al. Activation of negative regulators of the hypoxia-inducible factor (HIF) pathway in human end-stage heart failure. Biochem Biophys Res Commun. 2008;376(2):315–320.
   PubMed Web of Science ®Google Scholar
• Song CL, Wang JP, Xue X, et al. Effect of circular ANRIL on the inflammatory response of vascular endothelial cells in a rat model of coronary atherosclerosis. Cell Physiol Biochem. 2017;42(3):1202–1212.
   PubMedGoogle Scholar
• Zhang Z, Gao W, Long QQ, et al. Increased plasma levels of lncRNA H19 and LIPCAR are associated with increased risk of coronary artery disease in a Chinese population. Sci Rep. 2017;7(1):7491.
   PubMed Web of Science ®Google Scholar
• Zhou XJ, Li YW, Wu C, et al. Novel lncRNA XLOC_032768 protects against renal tubular epithelial cells apoptosis in renal ischemia–reperfusion injury by regulating FNDC3B/TGF-β1. Ren Fail. 2020;42(1):994–1003.
   PubMed Web of Science ®Google Scholar
• Bao S, Guo Y, Diao ZL, et al. Genome-wide identification of lncRNAs and mRNAs differentially expressed in human vascular smooth muscle cells stimulated by high phosphorus. Ren Fail. 2020;42(1):437–446.
   PubMed Web of Science ®Google Scholar
• Chade AR, Kelsen S. Renal microvascular disease determines the responses to revascularization in experimental renovascular disease. Circ Cardiovasc Interv. 2010;3(4):376–383.
   PubMed Web of Science ®Google Scholar
• He JQ, Shumansky K, Connett JE, et al. Association of genetic variations in the CSF2 and CSF3 genes with lung function in smoking-induced COPD. Eur Respir J. 2008;32(1):25–34.
   PubMed Web of Science ®Google Scholar
• Huang D, Song SJ, Wu ZZ, et al. Epstein-Barr virus-induced VEGF and GM-CSF drive nasopharyngeal carcinoma metastasis via recruitment and activation of macrophages. Cancer Res. 2017;77(13):3591–3604.
   PubMed Web of Science ®Google Scholar
• Ceylan A, Karasu C, Aktan F, et al. Effects of simvastatin treatment on oxidant/antioxidant state and ultrastructure of diabetic rat myocardium. Gen Physiol Biophys. 2003;22(4):535–547.
   PubMed Web of Science ®Google Scholar
• Cangemi R, Loffredo L, Carnevale R, et al. Early decrease of oxidative stress by atorvastatin in hypercholesterolaemic patients: effect on circulating vitamin E. Eur Heart J. 2007;29(1):54–62.
   PubMed Web of Science ®Google Scholar